Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somnidoron for minor sleep disorders
2006-005103-33Phase 4Completed
- Sponsor
- Weleda
- Start
- Nov 2006
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Somnidoron in sleep disorder, sponsored by Weleda. Primary endpoints: Change in sleep latency by actimetry and Change in sleep latency by sleep diary. Started Nov 2006; status: completed.
02
Drugs
Somnidoron
03
Conditions
sleep disorder
Beyond the preview
Go deeper on 2006-005103-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005103-33.